Certified by Founder Lodge
Alchemab Therapeutics Ltd
United Kingdom - London, England
START UP
1 Disclosed Funding Rounds $0
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and developm
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 10 ,2025 | Series A | Undisclosed Amount |
SV Health Investors
Lightstone Ventures
DCVC Bio
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Allos | $5,000,000 | (Jan 14, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
